WALTHAM, Mass.--(BUSINESS WIRE)--BG Medicine announced today that it has entered into a research collaboration with The University of Texas M. D. Anderson Cancer Center aimed at improving the treatment of breast cancer. Under this agreement, BG Medicine will apply its biomarker discovery technology to the analysis of clinical samples provided by The University of Texas M. D. Anderson Cancer Center. The goal of the collaboration is to identify novel, specific and sensitive blood-based protein and metabolite biomarkers in breast cancer patients who are receiving selected treatments.
